Seznam všech zadavatelů
Zobrazuji zprávy od zadavatele: Janssen-Cilag International
Nalezeno zpráv: 2
Janssen Receives Positive CHMP Opinion Recommending EDURANT® (rilpivirine) for the Treatment of Adolescents Aged 12 to <18 Years with HIV-1 infection
Zadavatel: Janssen-Cilag International
CHMP Announces Positive Opinion for REZOLSTA(TM), a New Once-Daily, Fixed-Dose HIV Therapy Combining Darunavir and Cobicistat
Zadavatel: Janssen-Cilag International
Nalezeno zpráv: 2